Celltrion
068270.KS
$128.90
Share price
0.11%
Change (1 day)
3.87%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Earnings for Celltrion (068270.KS)
Earnings in 2023 (TTM): $0.51 B
According to Celltrion 's latest financial reports the company's current earnings (TTM) are $0.51 B. In 2022 the company made an earning of $0.48 B a decrease over its 2021 earnings that were of $0.61 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Celltrion from 2008 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $0.51 B | 6.8% |
| 2022 | $0.48 B | -21.85% |
| 2021 | $0.61 B | 10.25% |
| 2020 | $0.55 B | 65.16% |
| 2019 | $0.33 B | 16.64% |
| 2018 | $0.28 B | -33.89% |
| 2017 | $0.43 B | 106.53% |
| 2016 | $0.21 B | 25.57% |
| 2015 | $0.16 B | -6.54% |
| 2014 | $0.18 B | 47.36% |
| 2013 | $0.12 B | -33.63% |
| 2012 | $0.18 B | |
| 2010 | $95.83 M | 72.84% |
| 2009 | $55.44 M | 260.54% |
| 2008 | $15.37 M |